-
LRRK2 Inhibition by BIIB122 / DNL151: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Ph 1 Healthy Volunteer and Ph 1B Parkinson’s Disease Trials
-
LY-487,379 alleviates parkinsonism when administered as monotherapy in the MPTP-lesioned marmoset
-
LY-487,379 enhances the anti-parkinsonian action of a low dose of L-DOPA in the MPTP-lesioned marmoset
-
Lysosomal storage disorder genes variants in Parkinson’s disease: a large cohort study in Chinese mainland population
-
Machine Learning (ML) Prediction of Parkinson’s Disease (PD) Risk and Nigral Neuron Density
-
Maintenance of physical activity (PA) mitigates worsening of patient-reported outcomes in Parkinson’s disease (PD) during the COVID-19 pandemic
-
Management of tremor secondary to MORC2 related neurodevelopmental disorder with deep brain stimulation
-
Mapping intrinsically photosensitive retinal ganglion cells (ipRGCs) dysfunction in patients with Parkinson disease using Chromatic pupilloperimetry
-
Mapping regional alpha-synuclein seeding capacity in Multiple System Atrophy
-
MAPT mutation frontotemporal dementia with parkinsonism: when previous results can skew the diagnosis
- « Previous Page
- 1
- …
- 72
- 73
- 74
- 75
- 76
- …
- 132
- Next Page »